Pyxis Oncology, Inc.
PYXS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $138,877 | $68,111 | $59,822 | $94,715 |
| - Cash | $8,919 | $10,733 | $12,759 | $19,473 |
| + Debt | $19,073 | $19,462 | $19,842 | $20,200 |
| Enterprise Value | $149,031 | $76,840 | $66,905 | $95,442 |
| Revenue | $0 | $2,820 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $2,820 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$21,468 | -$19,215 | -$22,362 | -$18,555 |
| % Margin | – | -681.4% | – | – |
| Net Income | -$22,003 | -$18,354 | -$21,158 | -$35,571 |
| % Margin | – | -650.9% | – | – |
| EPS Diluted | -0.35 | -0.3 | -0.35 | -0.58 |
| % Growth | -16.7% | 14.3% | 39.7% | – |
| Operating Cash Flow | -$13,277 | -$17,263 | -$22,535 | -$19,290 |
| Capital Expenditures | -$9 | $0 | $0 | $0 |
| Free Cash Flow | -$13,286 | -$17,263 | -$22,535 | -$19,290 |